Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CryoTreQ

K-Number: K202038 · 2020-12-30

ApplicantVitreQ BV
Decision Date2020-12-30
Product CodeHPS
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

CryoTreQ is a medical device manufactured by VitreQ BV. It received FDA 510(k) clearance on 2020-12-30 under approval number K202038. The device is classified under product code HPS. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CryoTreQ?

CryoTreQ is a medical device that received FDA 510(k) clearance on 2020-12-30. It is manufactured by VitreQ BV. The 510(k) number is K202038.

When was CryoTreQ approved by the FDA?

CryoTreQ received FDA 510(k) clearance on 2020-12-30, under approval number K202038.

What company makes CryoTreQ?

CryoTreQ is manufactured by VitreQ BV.

What is the FDA product code for CryoTreQ?

The FDA product code for CryoTreQ is HPS.

Other Devices by VitreQ BV

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.